Validation of a plasmonic-based serology biosensor for veterinary diagnosis of COVID-19 in domestic animals - INRAE - Institut national de recherche pour l’agriculture, l’alimentation et l’environnement Access content directly
Journal Articles Talanta Year : 2024

Validation of a plasmonic-based serology biosensor for veterinary diagnosis of COVID-19 in domestic animals

Abstract

The coronavirus disease 2019 (COVID-19) pandemic recently demonstrated the devastating impact on public health, economy, and social development of zoonotic infectious diseases, whereby viruses jump from animals to infect humans. Due to this potential of viruses to cross the species barrier, the surveillance of infectious pathogens circulation in domestic and close-to-human animals is indispensable, as they could be potential reservoirs. Optical biosensors, mainly those based on Surface Plasmon Resonance (SPR), have widely demonstrated its ability for providing direct, label-free, and quantitative bioanalysis with excellent sensitivity and reliability. This biosensor technology can provide a powerful tool to the veterinary field, potentially being helpful for the monitoring of the infection spread. We have implemented a multi-target COVID-19 serology plasmonic biosensor for the rapid testing and screening of common European domestic animals. The multi-target serological biosensor assay enables the detection of total SARS-CoV-2 antibodies (IgG + IgM) generated towards both S and N viral antigens. The analysis is performed in less than 15 min with a low-volume serum sample (<20 mu L, 1:10 dilution), reaching a limit of detection of 49.6 ng mL(-1). A complete validation has been carried out with hamster, dog, and cat sera samples (N = 75, including 37 COVID-19-positive and 38 negative samples). The biosensor exhibits an excellent diagnostic sensitivity (100 %) and good specificity (71.4 %) for future application in veterinary settings. Furthermore, the biosensor technology is integrated into a compact, portable, and user-friendly device, well-suited for point-of-care testing. This study positions our plasmonic biosensor as an alternative and reliable diagnostic tool for COVID-19 serology in animal samples, expanding the applicability of plasmonic technologies for decentralized analysis in veterinary healthcare and animal research.
Fichier principal
Vignette du fichier
2024_Giarola_Talanta.pdf (4.35 Mo) Télécharger le fichier
Origin Publisher files allowed on an open archive
Licence

Dates and versions

hal-04613923 , version 1 (17-06-2024)

Licence

Identifiers

Cite

Juliana Fátima Giarola, Maria Soler, M.-Carmen Estevez, Anna Tarasova, Sophie Le Poder, et al.. Validation of a plasmonic-based serology biosensor for veterinary diagnosis of COVID-19 in domestic animals. Talanta, 2024, 271, pp.125685. ⟨10.1016/j.talanta.2024.125685⟩. ⟨hal-04613923⟩
2 View
1 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More